[1] |
陈孝平,项帅. 精准医学时代肝门部胆管癌的治疗[J]. 中华消化外科杂志,2018,17(01):3-8.
|
[2] |
Bertuccio P,Malvezzi M,Carioli G,et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma[J]. J Hepatol,2019,71(1):104-114.
|
[3] |
Doherty B,Nambudiri VE,Palmer WC. Update on the diagnosis and treatment of cholangiocarcinoma[J]. Curr Gastroenterol Rep,2017,19(1):2.
|
[4] |
李年丰,冯思佳. NCCN肝胆肿瘤临床实践指南(2021.V1)胆管肿瘤诊治的解读[J]. 肝胆胰外科杂志,2021,33(09):513-518.
|
[5] |
蒋国军,赵丹,代义红. 近距内放疗联合经皮胆道支架治疗肝门胆管癌对黄疸复发及生存期的影响[J]. 现代消化及介入诊疗,2018,23(05):668-671.
|
[6] |
薛欢,王佩茹,王秀丽. 光动力疗法治疗肿瘤的免疫机制研究进展[J]. 国际免疫学杂志,2020,43(01):51-55.
|
[7] |
闫炫炫,李多富,李汛. 光动力疗法在不可切除肝门部胆管癌中的应用[J]. 中国普外基础与临床杂志,2018,25(04):488-492.
|
[8] |
卫怡蓉,彭鹏,杨海昆,等. 光动力疗法在不可切除肝外胆管癌的研究进展[J]. 现代消化及介入诊疗,2021,26(01):143-145,148.
|
[9] |
Li Z,Jiang X,Xiao H,et al. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma[J]. Surg Endosc,2021,35(10):5655-5664.
|
[10] |
Yang J,Shen H,Jin H,et al. Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy:A prospective study[J]. Photodiagnosis Photodyn Ther,2016,16:110-118.
|
[11] |
陈士明,娄玥,方煊,等. 光动力疗法联合支架引流与单独支架引流治疗不可切除胆管癌疗效的Meta分析[J]. 中华肝胆外科杂志,2018,24(09):616-621.
|
[12] |
Pereira P,Santos AL,Morais R,et al. Endoscopic radiofrequency ablation for palliative treatment of hilar cholangiocarcinoma[J]. VideoGIE,2021,6(4):195-198.
|
[13] |
De Jong DM,Cahen DL. Endoscopic radiofrequency ablation to prolong survival for unresectable extrahepatic biliary cancer[J]. Gastrointest Endosc,2021,94(1):101-102.
|
[14] |
邵杭锋,杨建锋. 射频消融治疗不可切除胆管癌研究进展[J]. 中华消化内镜杂志,2021,38(03):245-248.
|
[15] |
Yang J,Wang J,Zhou H,et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma:a randomized trial[J]. Endoscopy,2018,50(8):751-760.
|
[16] |
Mizandari M,Pai M,Xi F,et al. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction:feasibility and early results. Cardiovasc Intervent Radiol,2013,36(3):814-819.
|
[17] |
谢炬平,梁浩,张大伟,等. 内镜下射频消融联合金属支架植入对不可切除胆管癌的疗效[J]. 实用医学杂志,2018,34(09):1488-1490,1499.
|
[18] |
Laleman W,van der Merwe S,Verbeke L,et al. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice:the IGNITE-1 study[J]. Endoscopy,2017,49(10):977-982.
|
[19] |
Ruarus AH,Vroomen LGPH,Puijk RS,et al. Irreversible Electroporation in Hepatopancreaticobiliary Tumours[J]. Can Assoc Radiol J,2018,69(1):38-50.
|
[20] |
Tasu JP,Tougeron D,Rols MP. Irreversible electroporation and electrochemotherapy in oncology:State of the art[J]. Diagn Interv Imaging,2022,103(11):499-509.
|
[21] |
Franken LC,van Veldhuisen E,Ruarus AH,et al. Outcomes of Irreversible Electroporation for Perihilar Cholangiocarcinoma:A Prospective Pilot Study[J]. J Vasc Interv Radiol,2022,33(7):805-813.e1.
|
[22] |
Martin EK,Bhutiani N,Egger ME,et al. Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma[J]. HPB(Oxford),2018,20(11):1092-1097.
|
[23] |
Dollinger M,Müller-Wille R,Zeman F,et al. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up[J]. PLoS One,2015,10(8):e0135773.
|
[24] |
Hsiao CY,Yang PC,Li X,Huang KW. Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma[J]. Sci Rep,2020,10(1):10883.
|
[25] |
郭晋芳,张健康. 胆道支架置入及IRE治疗肝门部胆管癌的研究进展[J]. 现代消化及介入诊疗,2021,26(09):1190-1193.
|
[26] |
尹大龙,刘连新. 新辅助治疗在局部晚期肝门部胆管癌术前降期治疗中的应用价值[J]. 中华消化外科杂志,2020,19(12):1253-1256.
|